Patents Examined by P. Lynn Touzean
  • Therapeutic agent for threatened abortion
    Patent number: 5554593
    Abstract: Therapeutic agent for threatened abortion which contains human blood coagulation factor XIII as the active ingredient. Human blood coagulation factor XIII administered to patients with threatened abortion successfully treats the disease, and its effects are marked.
    Type: Grant
    Filed: December 23, 1994
    Date of Patent: September 10, 1996
    Assignee: Hoechst Japan Limited
    Inventors: Takayoshi Nakaya, Yayoi Kajiwara